Scientists have developed an in vitro stem cell-based bioassay grown on multi-electrode arrays capable of detecting the biological activity of Clostridium botulinum neurotoxins. Their assay could serve in minimizing animal experiments as well as provide a physiological relevant platform for drug-screening of neuroactive compounds.